| Application no. and date | 03757366.4 (espacenet) (Federated) (European Patent Register), 20030606 | | Patent/reg. no. and date | DK/EP 1531850, 20120222 | | Publication date | 20050525 | | Priority no. and date | US 387127 P, 20020607 | | EP pub. no. and date |
EP 1531850 20050525 | | Effective date | | | Applicant/owner | ZymoGenetics, Inc., 1201 Eastlake Avenue East
Seattle, WA 98102, US | | Applicant ref. no. | 11348-2.DK | | Inventor | HUGHES, Steven, D., 5530 NE 187th St.
Seattle, WA 98028, US,
HOLLY, Richard, D., 12539 10th Avenue NW
Seattle, WA 98177, US,
KINDSVOGEL, Wayne, R., 6014 24th Avenue NE
Seattle, WA 98115, US,
NELSON, Andrew, J., 5580 Doussin
Saint Leonard, Québec H1R 1B8, CA | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61P 31/04 (2006.01) , A61P 31/12 (2006.01) , A61P 35/00 (2006.01) | | Title | Anvendelse af 1L-21 og monoklonalt antistof til behandling af solide cancere | | Int. application no. | US2003017808 | | Int. publication no. | WO2003103589 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
